SanoBio Therapeutics is taking a novel peptide molecule proven to be highly effective at treating cutaneous wounds and commercializing it for the treatment of diabetic ulcers. Our immediate focus is to conduct further animal trials before filing an Investigational New Drug Application (IND) with the Federal Food and Drug Administration. Our long-term vision is to provide a safe and effective therapy for wound healing worldwide.
Company Details
- Employees
- 1
- Founded
- -
- Address
- 1220 S University Ave Suite 211, Ann Arbor,mi 48104,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.sanobio.com
- HQ
- Ann Arbor, MI
Sanobio Therapeutics Questions
Sanobio Therapeutics's website is http://www.sanobio.com
Sanobio Therapeutics's LinkedIn profile is https://www.linkedin.com/company/sanobio-therapeutics
Sanobio Therapeutics has
1 employees.
View email and phone details for 1
employees at Sanobio Therapeutics.
Sanobio Therapeutics's industry is
Pharmaceutical Manufacturing
Sanobio Therapeutics's top competitors are
Script Biosciences,
Multitude Therapeutics,
Seed Therapeutics,
Sanobiotec,
Bakar Bio Labs,
Axonis Therapeutics,
Regel Therapeutics,
Axent Biosciences,
Sania Therapeutics,
Scribe Therapeutics.
Sanobio Therapeutics's categories are Pharmaceutical Manufacturing
Sanobio Therapeutics's founding year is 2009
